TY - JOUR
TI - Human Immunodeficiency Virus Infection and Hypertension. Is There a Connection?
AU - Sanidas, E.
AU - Papadopoulos, D.P.
AU - Velliou, M.
AU - Tsioufis, K.
AU - Barbetseas, J.
AU - Papademetriou, V.
JO - American Journal of Hypertension
PY - 2018
VL - 31
TODO - 4
SP - 389-393
PB - Oxford University Press
SN - 0895-7061, 1941-7225
TODO - 10.1093/ajh/hpx208
TODO - anti human immunodeficiency virus agent;  antihypertensive agent, blood pressure;  drug effect;  drug interaction;  healthy lifestyle;  human;  Human immunodeficiency virus infection;  hypertension;  incidence;  pathophysiology;  polypharmacy;  prevalence;  prognosis;  risk assessment;  risk factor;  risk reduction;  virology, Anti-HIV Agents;  Antihypertensive Agents;  Blood Pressure;  Drug Interactions;  Healthy Lifestyle;  HIV Infections;  Humans;  Hypertension;  Incidence;  Polypharmacy;  Prevalence;  Prognosis;  Risk Assessment;  Risk Factors;  Risk Reduction Behavior
TODO - Data support that hypertension (HTN) is prevalent among human immunodeficiency virus (HIV) patients contributing to increased risk of cardiovascular disease. Immunodeficiency and prolonged antiretroviral treatment along with common risk factors including older age, male gender, and high body mass index might conduce to greater incidence of HTN. The purpose of this review was to summarize recent evidence of the increased cardiovascular risk in these patents linking HIV infection to HTN. © 2018 American Journal of Hypertension, Ltd.
ER -